PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Fluctuating blood pressure tied to problems with thinking skills

2024-12-11
(Press-News.org)

EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, DECEMBER 11, 2024

MINNEAPOLIS – Older adults whose blood pressure fluctuates over time may be more likely to have problems with thinking and memory skills, according to a study published in the December 11, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology. The association was found in Black participants but not in white participants in the study.  

The study does not prove that fluctuations in blood pressure cause problems with thinking skills; it only shows an association.

“These results suggest that fluctuation in blood pressure is a risk factor for cognitive problems beyond the negative effects of high blood pressure itself,” said study author Anisa Dhana, MD, MSc, of Rush University in Chicago. “Older adults should be routinely monitored for their blood pressure and any changes over time so we can identify people who may have this issue and work to alleviate it, which could potentially help to prevent or delay cognitive problems.”

The study involved 4,770 people with an average age of 71; 66% were Black participants, and the remaining were white participants.

Participants had blood pressure tests at the beginning of the study and then every three years for an average of 10 years. They also completed thinking and memory skills tests at the beginning and at their last visit.

Overall, the participants had an average blood pressure of 138/78 mmHg. High blood pressure is defined as 130/80 mmHg and higher.

Black participants in the study had an average variation over time in their systolic blood pressure, which is the top number, of 18 mmHg, compared to 16 mmHg for white participants.

The participants were divided into three groups based on how much their blood pressure varied over time. For Black participants, those with the most variability in their blood pressure had lower scores on the cognitive tests than those with the least variability. The difference in scores was the equivalent of 2.8 years of cognitive aging.

For people taking blood pressure medications at the start of the study, there was no difference in scores on thinking tests at the end of the study among the groups with high and low blood pressure variation.

“With our aging society and the prevalence of Alzheimer’s disease, identifying prevention strategies to slow the decline of cognitive skills in older adults has become a public health priority,” Dhana said. “Managing blood pressure and its fluctuations is emerging as an essential risk factor that can be modified.”

A limitation of the study is that participants were Black and white people, so the results may not apply to people of other races.  

The study was supported by the National Institute on Aging and the Alzheimer’s Association.

Discover more about brain health at BrainandLife.org, from the American Academy of Neurology. This resource also offers a magazine, podcast, and books that connect patients, caregivers and anyone interested in brain health with the most trusted information, straight from the world’s leading experts in brain health. Follow Brain & Life® on Facebook, X and Instagram.

The American Academy of Neurology is the leading voice in brain health. As the world’s largest association of neurologists and neuroscience professionals with more than 40,000 members, the AAN provides access to the latest news, science and research affecting neurology for patients, caregivers, physicians and professionals alike. The AAN’s mission is to enhance member career fulfillment and promote brain health for all. A neurologist is a doctor who specializes in the diagnosis, care and treatment of brain, spinal cord and nervous system diseases such as Alzheimer's disease, stroke, concussion, epilepsy, Parkinson's disease, multiple sclerosis, headache and migraine.

Explore the latest in neurological disease and brain health, from the minds at the AAN at AAN.com or find us on Facebook, X, Instagram, LinkedIn and YouTube.

END



ELSE PRESS RELEASES FROM THIS DATE:

Scientists find promising new target for antidepressants—in the gut

2024-12-11
Researchers have discovered new connections between the gut and brain that hold promise for more targeted treatments for depression and anxiety, and could help prevent digestive issues in children by limiting the transmission of antidepressants during pregnancy.  The study, published in the journal Gastroenterology, shows that increasing serotonin in the gut epithelium—the thin layer of cells lining the small and large intestines—improves symptoms of anxiety and depression in animal studies. The researchers also found ...

Antidepressants may act in gut to reduce depression and anxiety

2024-12-11
NEW YORK, NY (Dec. 11, 2024)--Most of us have experienced the effects of moods and emotions on our gastrointestinal tract, from “butterflies” in the stomach caused by nervousness to a loss of appetite when we’re feeling blue. A new study in animals suggests that targeting antidepressant medications to cells in the gut could not only be an effective treatment of mood disorders like depression and anxiety but may also cause fewer cognitive, gastrointestinal, and behavioral side effects for patients and their children than current treatments. “Antidepressants like Prozac and Zoloft that raise serotonin levels are important first-line ...

New PROSPECT-lung trial launches to advance treatment options for operable non-small cell lung cancer

2024-12-11
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung cancer. The trial, which is the first to open through the newly formed National Cancer Institute (NCI) Clinical Trials Innovation Unit (CTIU), aims to evaluate the role of immunotherapy before and after surgery in patients with non-small cell lung cancer. The PROSPECT-Lung trial is a large, multicenter trial developed and led by the Alliance for Clinical Trials in Oncology and the SWOG Cancer Research Network and conducted within the NIH-funded NCI National Clinical Trials Network (NCTN), ...

The Welch Foundation honors Rice’s Wang for pioneering contributions to sustainable energy solutions

The Welch Foundation honors Rice’s Wang for pioneering contributions to sustainable energy solutions
2024-12-11
The Welch Foundation, one of the nation’s leading private funders of basic chemistry research, has awarded the 2025 Norman Hackerman Award in Chemical Research to Haotian Wang, an associate professor in the Department of Chemical and Biomolecular Engineering at Rice University. Wang is recognized for his groundbreaking contributions to carbon dioxide electrochemistry, which pave the way for sustainable energy solutions. Wang’s innovative research focuses on harnessing the catalyst-electrolyte ...

Hospital payment caps could save millions of dollars for state employee health plans

2024-12-11
PROVIDENCE, R.I. [Brown University] — State employee health plans could have saved $7.1 billion nationwide by capping hospital payments at 200% of Medicare rates in 2022, a study led by researchers at the Brown University School of Public Health found. “States are under growing budgetary pressure due to rising health care spending, primarily through increases in hospital and drug prices,” said study author Roslyn Murray, an assistant professor of health services, policy and practice ...

Intraarterial radionuclide therapy safe and effective for advanced meningioma patients

Intraarterial radionuclide therapy safe and effective for advanced meningioma patients
2024-12-11
Reston, VA (December 10, 2024)—Radionuclide therapy delivered directly to an artery is safe and feasible for patients with advanced meningioma, according to new research published in the December issue of The Journal of Nuclear Medicine. In the first long-term study of intraarterial peptide receptor radionuclide therapy (PRRT) in advanced meningioma, patients saw improved radiologic and clinical disease control compared with intravenous PRRT, with no additional toxicity. Meningiomas are the most common primary neoplasms of the central nervous system and account for more than one-third of all cases. Meningiomas are mostly ...

University of Tennessee and Sheffield sign MOU to facilitate collaborations

University of Tennessee and Sheffield sign MOU to facilitate collaborations
2024-12-11
The University of Tennessee and the University of Sheffield recently signed a memorandum of understanding to facilitate educational and research collaborations, share best practices, and promote student and staff exchanges between the institutions.   Tickle College of Engineering Dean Matthew Mench, the Wayne T. Davis Dean’s Chair, traveled to England in late November to tour the Sheffield facilities, meet with faculty, and sign the MOU with Malcolm Butler, the vice president and director of global engagement of the University of Sheffield.  There ...

Nemours Children’s Health Initiative to start HPV vaccination at age 9 improved completion rates

2024-12-11
WILMINGTON, Del. (December 11, 2024) — A quality improvement program designed to increase earlier uptake of the human papillomavirus (HPV) vaccine raised vaccination rates significantly, according to a study by Nemours Children’s Health researchers. In a new study published in Academic Pediatrics, Caitlin J. Miller, medical student at Sidney Kimmel Medical College of Thomas Jefferson University and Jonathan Miller, MD, Associate Chief of Primary Care, Nemours Children’s ...

Nova SBE and New York University Tandon School of Engineering launch transatlantic dual degree program

2024-12-11
Nova School of Business and Economics (Nova SBE) has partnered with NYU Tandon School of Engineering  to  create a transatlantic program focusing on two strategic and complementary fields: Management (Nova SBE) and Management of Technology (NYU Tandon). This new program allows students to earn distinct master’s degrees from two of the world’s most prestigious academic institutions, located in key cultural and economic centers: Lisbon and New York.  Under this partnership agreement, students enrolled in either the International Master’s in Management or the Master’s in Management (both from Nova SBE) ...

2025 SPIE-Franz Hillenkamp Postdoctoral Fellowship awarded to Morgan Fogarty

2025 SPIE-Franz Hillenkamp Postdoctoral Fellowship awarded to Morgan Fogarty
2024-12-11
BELLINGHAM, Washington, USA — SPIE, the international society for optics and photonics, has announced Morgan Fogarty, who is expected to receive her PhD in Imaging Science from Washington University in St. Louis (WashU) in February, as the recipient of the 2025 SPIE-Franz Hillenkamp Postdoctoral Fellowship in Problem-Driven Biomedical Optics and Analytics. The annual award of $75,000 supports interdisciplinary problem-driven research and provides opportunities for translating new technologies ...

LAST 30 PRESS RELEASES:

Psilocybin shows context-dependent effects on social behavior and inflammation in female mice modeling anorexia

Mental health crisis: Global surveys expose who falls through the cracks and how to catch them

New boron compounds pave the way for easier drug development

Are cats ‘vegan’ meat eaters? Study finds why isotopic fingerprint of cat fur could trick us into thinking that way

Unexpected partial recovery of natural vision observed after intracortical microstimulation in a blind patient

From sea to soil: Molecular changes suggest how algae evolved into plants

Landmark study to explore whether noise levels in nurseries affect babies’ language development

Everyday diabetes medicine could treat common cause of blindness

Ultra-thin metasurface chip turns invisible infrared light into steerable visible beams

Cluster radioactivity in extreme laser fields: A theoretical exploration

Study finds banning energy disconnections shouldn’t destabilise markets

Researchers identify novel RNA linked to cancer patient survival

Poverty intervention program in Bangladesh may reinforce gender gaps, study shows

Novel approach to a key biofuel production step captures an elusive energy source

‘Ghost’ providers hinder access to health care for Medicaid patients

Study suggests far fewer cervical cancer screenings are needed for HPV‑vaccinated women

NUS CDE researchers develop new AI approach that keeps long-term climate simulations stable and accurate

UM School of Medicine launches clinical trial of investigative nasal spray medicine to prevent illnesses from respiratory viruses

Research spotlight: Use of glucose-lowering SGLT2i drugs may help patients with gout and diabetes take fewer medications

Genetic system makes worker cells more resilient producers of nanostructures for advanced sensing, therapeutics

New AI model can assist with early warning for coral bleaching risk

Highly selective asymmetric 1,6-addition of aliphatic Grignard reagents to α,β,γ,δ-unsaturated carbonyl compounds

Black and Latino teens show strong digital literacy

Aging brains pile up damaged proteins

Optimizing robotic joints

Banning lead in gas worked. The proof is in our hair

Air pollution causes social instability in ant colonies

Why we sleep poorly in new environments: A brain circuit that keeps animals awake 

Some tropical land may experience stronger-than-expected warming under climate change

Detecting early-stage cancers with a new blood test measuring epigenetic instability

[Press-News.org] Fluctuating blood pressure tied to problems with thinking skills